Back to JNJ Stock Lookup

JNJ Related Analyst Comments

Apr 19, 2013 08:18 AM Jefferies Trims Estimates, Ups PT on Johnson & Johnson (JNJ) Post Q1

Apr 17, 2013 10:49 AM Goldman Maintains Sell on Johnson & Johnson (JNJ); Drug Business Spin Still Unlikely

Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)

Apr 1, 2013 11:47 AM Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation

Mar 26, 2013 04:24 PM Q1 Not Super Important for Johnson & Johnson (JNJ), But New Products Are - UBS

Feb 28, 2013 03:47 PM Medivation (MDVN) Reverses after Cowen Research Called into Question by Janney

Sep 26, 2012 11:29 AM Refinancing of Debt Helps Alkermes (ALKS) Save Cash, MKM Reiterates Buy, Raises PT

Sep 19, 2012 10:22 AM Wedbush Prostate Cancer Survey Reveals JNJ’s (JNJ) Zytiga has Still-Solid Market Position but Medivation’s (MDVN) Xtandi in Good Position at Launch

Sep 4, 2012 01:55 PM Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT on Early Approval

Sep 4, 2012 10:51 AM Leerink Swann Maintains an 'Outperform' on Medivation (MDVN); Number of Advantages Based on Labeling

Aug 6, 2012 09:19 AM Sell-Off in VIVUS (VVUS) Over Qsymia Patent Concerns is Overdone - Analyst

Aug 1, 2012 12:10 PM UBS Reiterates a 'Buy' on Johnson & Johnson (JNJ); Diving Into Valuation

Jul 25, 2012 12:52 PM Canaccord Genuity Afternoon Coffee on PFE, ELN, and JNJ: I Just Forgot What I Was About to Say

Jul 24, 2012 02:16 PM UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Bapineuzumab Misses on ApoE4 Carriers

Jul 24, 2012 10:15 AM Canaccord Genuity Morning Coffee on Dogs of the Dow: I'm Large and In Charge

Jul 18, 2012 11:31 AM Jefferies Boosts PT on J&J (JNJ) Following Q2 Results; Watching 'Strategic Review,' Synthes Integration

Jul 17, 2012 09:10 AM RBC Capital Negative on Dendreon (DNDN) Ahead of Q2 Results

Jul 16, 2012 02:24 PM Q2 Preview: Eyes on J&J's (JNJ) New CEO Gorsky Into Print, Conference Call

Jul 16, 2012 09:49 AM S&P 500 (SPY) is Going Higher Because Analyst Carter Worth Says So

Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?

Jul 12, 2012 09:10 AM Citi Removes Apple (AAPL) from 'Champions' List; Adds GE (GE), J&J (JNJ), Ford (F)

Jun 29, 2012 03:51 PM Barclays on Pharmaceutical Stocks: Impact as SCOTUS Upholds Entire Affordable Care Act

Jun 21, 2012 12:28 PM Analyst Sees Dendreon's (DNDN) Efforts to Boost Provenge Demand Bearing Fruit in Q4; Shares Jump

Jun 14, 2012 11:27 AM Canccord Genuity Morning Coffee on Johnson & Johnson (JNJ); Good for the Bones, ja!

Jun 12, 2012 11:37 AM UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); CANA Standout at ADA

Jun 12, 2012 10:19 AM Canaccord Genuity Morning Coffee on Johnson & Johnson (JNJ): Big Legal Bills To Get Bigger

Jun 11, 2012 05:17 PM Barclays on Global Biopharma Stocks: American Diabetes Association 2012: Highlights From GSK, LLY, SNY, NVO & JNJ

Jun 4, 2012 11:33 AM Deutsche Bank Defends Dendreon (DNDN) Despite Strong Zytiga Data; Maintains Buy

Jun 4, 2012 09:37 AM Brean Murray Carret & Co. Maintains a 'Buy' on Medivation (MDVN); Zytiga Data Better Than Expected

Jun 4, 2012 09:29 AM Deutsche Bank Maintains a 'Hold' on Johnson & Johnson (JNJ); Phase 3 Data for Zytiga Shows Meaningful Results

Jun 4, 2012 09:09 AM Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT and 2013 Estimates

May 17, 2012 10:40 AM Dendreon (DNDN) Hit On Various Worries, Deutsche Bank Defends

May 16, 2012 10:20 AM Canaccord Genuity Morning Coffee on Avon Products (NYSE: AVP): Even Concealer Can't Fix This Mess

May 11, 2012 01:26 PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium

May 9, 2012 10:40 AM Auriga Maintains a 'Buy' on Perrigo Co. (PRGO); Accumulate Shares on Weakness

May 1, 2012 02:39 PM Cantor Fitzgerald Maintains a 'Buy' on Warner Chilcott (WCRX); Let's Make It Official

Apr 23, 2012 10:14 AM Auriga Reiterates a 'Buy' on Perrigo Co. (PRGO); Recent Data Points Underscore Thesis

Apr 18, 2012 01:14 PM UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Held Back By Slow EPS Growth

Apr 16, 2012 04:13 PM Q1 Preview: Bellwether Johnson & Johnson (JNJ) has New CEO, Patent Expiration on Its Plate

Apr 12, 2012 09:52 AM Citi Cuts Dendreon (DNDN) Price Target to $10 Amid 'Significant Threats to Provenge'

Mar 22, 2012 09:32 AM Jefferies Maintains a 'Buy' on Medivation (MDVN)); PREVAIL Trial Design Increases Odds of Success

Mar 12, 2012 10:44 AM Canaccord Genuity Morning Coffee on Dendreon (DNDN) and Johnson & Johnson (JNJ): Honeydew Sized Prostate

Mar 8, 2012 12:18 PM Dendreon's (DNDN) Provenge Hit With a Setback, But Valuation Getting Interesting - Baird

Mar 8, 2012 09:30 AM Deutsche Bank Maintains a 'Buy' on Dendreon (DNDN): Buyers on Any Weakness

Mar 1, 2012 09:07 AM VIVUS (VVUS) Could Be Bought For Up to $40/Share

Feb 16, 2012 10:06 AM Canaccord Genuity Reiterates a 'Buy' on Insulet (PODD); Second Partner Creates Future Opportunity

Feb 8, 2012 08:27 AM Needham & Company maintains a 'Hold' on Perrigo Co. (PRGO); Q2 Outpaces Despite Some Segmental Head Winds

Feb 2, 2012 10:53 AM Canaccord Genuity Morning Coffee on Dogs of the Dow: If You Gotta Shoot, Aim High

Jan 30, 2012 01:17 PM Q4 Preview: Pfizer (PFE) May Suffer Same Ailment as Peers: Strong Dollar Syndrome

Jan 25, 2012 10:42 AM Canaccord Genuity Morning Coffee on Johnson & Johnson (JNJ): Hips Don't Lie

Back to JNJ Stock Lookup